Neurex Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurex Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cody Goebel who wrote (368)	11/8/1997 9:41:00 PM
From: John McCarthy	Read Replies (1) of 449

Cody - I think you know this already, but for anyone else techstocks.com Basically: (1) SNX-111 NDA filing expected mid 1998. (2) SNX-111 clinical study in Europe for severe pain initiated. (3) SNX-111 Phase 3 for head trauma initiated. Ok, I'll ask:For what indication is the mid 1998 filing for? I'd assume that it is for pain? Note: Cash:$68.0 mil. Qtr R&D:$8.0 mil. Regards, John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next